| Literature DB >> 35751878 |
Torunn Oveland Apelseth1,2,3, Mirjana Arsenovic4, Geir Strandenes1.
Abstract
BACKGROUND: Civilian and military guidelines recommend early balanced transfusion to patients with life-threatening bleeding to improve survival. To provide the best care to patients with hemorrhagic shock in regions with reduced access to evacuation, blood preparedness must be ensured also on a municipal health care level. The primary aim of the Norwegian Blood Preparedness project is to enable rural hospitals, prehospital ambulance services, and municipal health care services to start early balanced blood transfusions for patients with life-threatening bleeding regardless of etiology. STUDY DESIGN AND METHODS: The project is designed based on three principles: (1) Early balanced transfusion should be provided for patients with life-threatening bleeding, (2) Management of an emergency requires a planned and rehearsed day-to-day system for blood preparedness, and (3) A decentralized system is needed to ensure local self-sufficiency in an emergency. We developed a system for education and training in blood-based resuscitation with a focus on the municipal health care service.Entities:
Keywords: arctic region; bleeding; blood preparedness; emergency blood transfusion; health care; prehospital transfusion; rural hospitals; transfusion management; walking blood bank; whole blood
Mesh:
Year: 2022 PMID: 35751878 PMCID: PMC9543315 DOI: 10.1111/trf.16968
Source DB: PubMed Journal: Transfusion ISSN: 0041-1132 Impact factor: 3.337
An overview of the Norwegian blood preparedness project
| Rural hospital with hospital‐based blood bank | Prehospital health care services | Municipal health care | |
|---|---|---|---|
| Emergency blood transfusion program | Stored blood. Emergency collection of fresh whole blood from regular blood donors if needed. |
Stored LTOWB provided by civilian blood bank. Dried plasma. |
Fresh LTOWB collected from preplanned walking blood bank. Dried plasma. |
Abbreviation: LTOWB, low titer group O whole blood.
Comparison between the walking blood bank and the hospital based whole blood program in the Norwegian blood preparedness pilot project
| Preplanned walking blood Bank | Hospital based blood Bank | |
|---|---|---|
| Blood donor | ||
| Donor status | Emergency whole blood donor | Regular whole blood donor |
| Blood type |
Low titer O High titer O considered if needed. |
Low titer O ABO‐type like considered if needed. |
| Donor gender | Both male and female | Both male and female |
| Transfusion transmittable disease testing | At inclusion, every 6 months, and at donation (sample taken at donation but results not available before emergency transfusion of whole blood, posttransfusion testing) | At inclusion and at donation. |
| Interview |
At inclusion, every 6 months, and at donation. Before an emergency donation a screening interview are performed. | At inclusion and at donation. |
| Documentation of donation |
Screening interview form and standard interview form filled out and signed by donor and interviewer. Donation documented by use of donation form at WBB collection site. Postdonation registration performed electronically by Mother Blood Bank. |
Interview form filled out by donor and signed by donor and interviewer. Interview and donation documented electronically at donation. |
| Whole blood unit | ||
| Volume | 450 ml | 450 mL |
| Anti‐coagulant | CPDA‐1 | CPD |
| Processing of whole blood unit after collection | No further processing | Leukoreduced with a platelet‐sparing filter |
| Storage | No storage | 21 days without agitation |
| Storage temperature | Not applicable | 2–6 °C |
| Transfusion transmittable disease (TTD) testing | Posttransfusion (Only donors with negative TTD tests within the past 6 months are accepted for donation) | Before transfusion |
Low titer defined as <256 for IgM and IgG anti‐A and anti‐B.
Additional testing of female donors: anti‐HLA, anti‐HNA and anti‐HPA.
HIV, hepatitis B and hepatitis C.
CPDA‐1, citrate–phosphate‐dextrose‐adenine‐1; CPD, citrate–phosphate‐dextrose.